Detalhe da pesquisa
1.
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid.
J Antimicrob Chemother
; 77(6): 1685-1693, 2022 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260883
2.
Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 65(12): e0138121, 2021 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543098
3.
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
Antimicrob Agents Chemother
; 65(11): e0036421, 2021 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460307
4.
Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.
J Antimicrob Chemother
; 75(5): 1123-1129, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32016320
5.
Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection.
Antimicrob Agents Chemother
; 63(3)2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617089
6.
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis.
Am J Respir Crit Care Med
; 198(9): 1208-1219, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29877726
7.
The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
J Antimicrob Chemother
; 73(10): 2667-2674, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982641
8.
Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
J Infect Dis
; 216(6): 632-640, 2017 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934422
9.
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
Clin Infect Dis
; 64(10): 1350-1359, 2017 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28205671
10.
Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.
Antimicrob Agents Chemother
; 59(1): 38-45, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25313213
11.
Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study.
Lancet
; 383(9924): 1230-9, 2014 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24439237
12.
Minority Mycobacterium tuberculosis Genotypic Populations as an Indicator of Subsequent Phenotypic Resistance.
Am J Respir Cell Mol Biol
; 61(6): 789-791, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31774334
13.
Moxifloxacin retains antimycobacterial activity in the presence of gyrA mutations.
Antimicrob Agents Chemother
; 58(5): 2912-5, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24514091
14.
Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients.
Antimicrob Agents Chemother
; 58(1): 503-10, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24189253
15.
The pyrazinamide susceptibility breakpoint above which combination therapy fails.
J Antimicrob Chemother
; 69(9): 2420-5, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821594
16.
Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa.
Emerg Infect Dis
; 19(3): 449-55, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23622714
17.
gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
J Antimicrob Chemother
; 67(5): 1088-93, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22357804
18.
embB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis.
Chemotherapy
; 58(5): 358-63, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23171739
19.
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action Studies.
J Med Chem
; 64(1): 719-740, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33395287
20.
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in Mycobacterium tuberculosis.
J Med Chem
; 64(17): 12790-12807, 2021 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34414766